Plain-English translation of NCT03424005 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
The Morpheus-panBC trial is testing different combinations of cancer medications—including , , , and others—to see which work best for people with advanced breast cancer. Researchers are organizing participants into groups based on their tumor's genetic profile and prior treatments, so each group receives the combination most likely to help them. The goal is to find the most effective and safest treatment options for different types of advanced breast cancer.
Current treatments for advanced breast cancer don't work for everyone, and some people develop resistance to therapies over time. This trial exists to test whether newer medication combinations—especially those that work with the body's immune system or target specific genetic changes in tumors—can help more patients live longer with better quality of life.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital or clinic regularly to receive your assigned medication combination intravenously or by mouth, depending on which treatment group you're in. Your doctor will monitor you closely with blood tests and imaging scans to see how well the treatment is working and to watch for side effects. The study involves two stages: in Stage 1, you'll receive your first treatment combination; if it doesn't work or causes problems, Stage 2 may allow you to switch to a different combination. Treatment continues as long as the medication is helping and side effects remain manageable.
AI-generated summary from trial data · Sep 15, 2026 · Not medical advice
United States